HCA

SEC source: 0001209191-20-011758 · doc4.xml · nonDerivative · entry 2

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,089

SEC source: 0001209191-20-011758 · doc4.xml · nonDerivative · entry 1

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,704

F1 · kind: On February 1, 2017, the reporting person was granted 9,910 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted.

SEC source: 0001209191-20-011757 · doc4.xml · nonDerivative · entry 2

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,203

SEC source: 0001209191-20-011757 · doc4.xml · nonDerivative · entry 1

Foster Jon M · CIK 0001513235 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,819

F1 · kind: On February 1, 2017, the reporting person was granted 9,910 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted.

SEC source: 0001209191-20-011756 · doc4.xml · nonDerivative · entry 2

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,989

SEC source: 0001209191-20-011756 · doc4.xml · nonDerivative · entry 1

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,158

F1 · kind: On February 1, 2017, the reporting person was granted 3,970 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted.

SEC source: 0001209191-20-011747 · doc4.xml · nonDerivative · entry 2

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,763.0188

SEC source: 0001209191-20-011747 · doc4.xml · nonDerivative · entry 1

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,556.0188

F1 · kind: On February 1, 2017, the reporting person was granted 2,650 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted.

SEC source: 0001209191-20-011755 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,612.2078

SEC source: 0001209191-20-011755 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,469.2078

F1 · kind: On February 1, 2017, the reporting person was granted 8,260 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted.

SEC source: 0001209191-20-011746 · doc4.xml · nonDerivative · entry 2

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,847

SEC source: 0001209191-20-011746 · doc4.xml · nonDerivative · entry 1

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,449

F1 · kind: On February 1, 2017, the reporting person was granted 1,990 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted.

SEC source: 0001209191-21-010853 · doc5.xml · nonDerivative · entry 5

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by GRATs

Disclosed balance after: 4,854,383.3737

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F4 · ownership.nature: The Reporting Person is trustee of three grantor retained annuity trusts for the benefit of her children, and the Reporting Person's spouse is trustee of three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may, accordingly, be deemed to be the beneficial owner of the aggregate 116,766 shares of common stock of HCA Healthcare, Inc. held by such trusts. In addition, the Reporting Person may be deemed to be the beneficial owner of the 7,560,060.255067 units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-21-010853 · doc5.xml · nonDerivative · entry 4

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by Elcan Investment Partnership

Disclosed balance after: 0

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F3 · ownership.nature: The Reporting Person may be deemed to be the beneficial owner of the shares of common stock of HCA Healthcare, Inc. and the units of Hercules held by Elcan Investment Partnership, of which Mrs. Elcan, her spouse and a trust of which Mrs. Elcan and her spouse serve as co-trustees are the general partners. The Reporting Person therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-21-010853 · doc5.xml · nonDerivative · entry 3

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by Elcan Children's Trust

Disclosed balance after: 0

F1 · ownership.nature: The Reporting Person's spouse is trustee of (i) the Patricia F. Elcan GRAT III Trust II, (ii) the Patricia F. Elcan GRAT II Trust I and (iii) the Elcan Children's Trust, and the Reporting Person may therefore be deemed to be the beneficial owner of the shares of common stock of HCA Healthcare, Inc. and the units of Hercules Holding II ("Hercules") held by such trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

SEC source: 0001209191-21-010853 · doc5.xml · nonDerivative · entry 2

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by Patricia F. Elcan GRAT II Trust I

Disclosed balance after: 0

F1 · ownership.nature: The Reporting Person's spouse is trustee of (i) the Patricia F. Elcan GRAT III Trust II, (ii) the Patricia F. Elcan GRAT II Trust I and (iii) the Elcan Children's Trust, and the Reporting Person may therefore be deemed to be the beneficial owner of the shares of common stock of HCA Healthcare, Inc. and the units of Hercules Holding II ("Hercules") held by such trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

SEC source: 0001209191-21-010853 · doc5.xml · nonDerivative · entry 1

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by Patricia F. Elcan GRAT III Trust II

Disclosed balance after: 0

F1 · ownership.nature: The Reporting Person's spouse is trustee of (i) the Patricia F. Elcan GRAT III Trust II, (ii) the Patricia F. Elcan GRAT II Trust I and (iii) the Elcan Children's Trust, and the Reporting Person may therefore be deemed to be the beneficial owner of the shares of common stock of HCA Healthcare, Inc. and the units of Hercules Holding II ("Hercules") held by such trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

SEC source: 0001209191-20-011764 · doc4.xml · nonDerivative · entry 2

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust (Spouse, Trustee)

Disclosed balance after: 2,364

SEC source: 0001209191-20-011764 · doc4.xml · nonDerivative · entry 1

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,928.1196

SEC source: 0001209191-20-010371 · doc4.xml · derivative · entry 8

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 20,000 shares

Expires 2025-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.

SEC source: 0001209191-20-010371 · doc4.xml · derivative · entry 7

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,500 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.

SEC source: 0001209191-20-010371 · doc4.xml · derivative · entry 6

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,875 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-20-010371 · doc4.xml · nonDerivative · entry 4

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,025

SEC source: 0001209191-20-010371 · doc4.xml · nonDerivative · entry 3

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 248,939

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-010371 · doc4.xml · nonDerivative · entry 2

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 228,939

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-010369 · doc4.xml · derivative · entry 4

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,025

Underlying: Common Stock · 10,175 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-20-010369 · doc4.xml · nonDerivative · entry 2

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,167

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-010369 · doc4.xml · nonDerivative · entry 1

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-009739 · doc4.xml · nonDerivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,484

F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-008415 · doc4.xml · nonDerivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,964

SEC source: 0001209191-20-010371 · doc4.xml · nonDerivative · entry 1

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,564

SEC source: 0001209191-20-046666 · doc4.xml · nonDerivative · entry 6

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Indirect · By TCM Trust (Spouse, Trustee)

Disclosed balance after: 40,552

SEC source: 0001209191-20-046666 · doc4.xml · nonDerivative · entry 5

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Indirect · By 2017 GRAT

Disclosed balance after: 0

SEC source: 0001209191-20-046666 · doc4.xml · nonDerivative · entry 4

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Indirect · By MRM Trust (Spouse, Trustee)

Disclosed balance after: 44,498

SEC source: 0001209191-20-046666 · doc4.xml · nonDerivative · entry 3

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Indirect · By 2017 GRAT

Disclosed balance after: 14,648

SEC source: 0001209191-20-046666 · doc4.xml · nonDerivative · entry 2

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Indirect · By MAM Trust (Spouse, Trustee)

Disclosed balance after: 40,552

SEC source: 0001209191-20-046666 · doc4.xml · nonDerivative · entry 1

MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line

10b5-1 filing: Not disclosed

Ownership: Indirect · By 2017 GRAT

Disclosed balance after: 29,296

SEC source: 0001209191-20-007737 · doc4.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,977

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.15 to $149.18, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-007735 · doc4.xml · nonDerivative · entry 1

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,480

F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-007736 · doc4.xml · derivative · entry 7

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,297

Underlying: Common Stock · 3,433 shares

Expires 2028-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.

SEC source: 0001209191-20-007736 · doc4.xml · derivative · entry 6

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,495 shares

Expires 2026-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017.

SEC source: 0001209191-20-007736 · doc4.xml · derivative · entry 5

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2025-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016.

SEC source: 0001209191-20-007736 · doc4.xml · nonDerivative · entry 4

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,534

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-007736 · doc4.xml · nonDerivative · entry 3

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,912

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-007736 · doc4.xml · nonDerivative · entry 2

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,479

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-007736 · doc4.xml · nonDerivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,984

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-007733 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,734.2078

F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-007287 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 646

F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-005892 · doc4.xml · derivative · entry 5

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,160

Underlying: Common Stock · 44,160 shares

Expires 2030-01-29

F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021.

SEC source: 0001209191-20-005881 · doc4.xml · derivative · entry 5

Hall Charles J · CIK 0001377791 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,880

Underlying: Common Stock · 35,880 shares

Expires 2030-01-29

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021.